| Title: |
Blautia luti Regulates Risk of Mucosal Injury and Gastrointestinal Symptoms Caused by Chemotherapy. |
| Authors: |
Secombe, Kate R.; da Silva Ferreira, Ana R.; Simpson, Hanna L.; Bispo, Mafalda; Stringer, Andrea M.; Gibson, Rachel J.; Tissing, Wim J. E.; Harmsen, Hermie H. M.; Bowen, Joanne M.; Wardill, Hannah R.; Yu, Jiong |
| Source: |
Advanced Gut & Microbiome Research; 4/11/2026, Vol. 2026, p1-15, 15p |
| Subject Terms: |
CHEMOTHERAPY complications; GUT microbiota; MICROBIAL communities; BACTERIA; PROBIOTICS; INTESTINAL mucosa; MUCOSITIS |
| Abstract: |
Gastrointestinal mucositis (GI‐M) is a dose‐limiting complication of chemotherapy initiated by direct cytotoxic injury to the intestinal epithelium. It is then perpetuated by aberrant immune responses driven by the host and their microbiota. GI‐M presentation is heterogeneous, hypothesized to be influenced by patient factors including genomic variability, comorbidities, and, more recently, unique gut microbiota signatures. We aimed to identify microbial attributes that differ between patients that developed GI‐M compared with those that did not and use this information to identify/characterize novel microbial biotherapeutics. Archived stool samples collected from N = 12 patients undergoing standard‐dose chemotherapy were used. GI‐M was defined using the CTCAE. Microbial composition was assessed by 16S rRNA gene sequencing and the most differentially abundant taxon, Blautia luti, was identified for in vitro characterization. Blautia luti supernatants (BLSPNs) were isolated and investigated in vitro. Of the 12 patients recruited, four were included in the "high toxicity" group. B. luti levels strongly correlated with toxicity outcomes (r = 0.744). Chemotherapy‐induced cell death in colonic epithelial cells was attenuated when treated prophylactically, concurrently, and therapeutically with BLSPN (p = 0.0087, p = 0.0022, and p = 0.0166, respectively). Notably, 20% BLSPN enhanced Roseburia intestinalis (p = 0.0015) and F. prausnitzii (p = 0.0007) growth, but prevented Escherichia coli outgrowth (p = 0.0002) under oxidative conditions. In conclusion, B. luti strongly correlates with GI‐M risk and demonstrates in vitro behaviors that address defined drivers of GI‐M etiology. [ABSTRACT FROM AUTHOR] |
| : |
Copyright of Advanced Gut & Microbiome Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |